Morrisville’s $1 billion biotech hub announces its first tenant, a German company
AI-generated summary reviewed by our newsroom.
- German firm Coriolis Pharma will invest $10M in Spark LS, creating 50 jobs.
- Morrisville beat Boston and San Diego due to airport access and nearby schools.
- Coriolis' lab marks Spark LS’s first tenant amid uncertain biotech space demand.
After sitting empty for seven months, the Spark Life Science, or Spark LS, hub in Morrisville has its first tenant.
Coriolis Pharma, a pharmaceutical services company based in Germany, is investing $10 million to build a laboratory at Spark LS. The company and the town of Morrisville announced the investment Tuesday in the lobby of the Spark LS building.
Founded in 2008, Coriolis helps drugmakers take biomolecules and turn them into medicines. It serves over 800 clients worldwide.
Coriolis’ laboratory will span 13,000 square feet. The Spark LS campus spans over 1 million square feet. Coriolis co-founder Dr. Michael Wiggenhorn said the company would create an initial 50 jobs.
Wake County Board of Commissioners Chair Susan Evans said Coriolis considered several other cities, including San Francisco, Boston and San Diego. But being next to RDU International Airport and universities like Duke, N.C. State and UNC-Chapel Hill gave Morrisville the edge, she said.
“We’ve worked hard over the years, along with our municipalities like Morrisville, to gain that sterling reputation, and now, we’re sharing the fruits of that labor,” Evans said.
Coriolis will receive an Upward Mobility bonus — an additional 5% in tax rebates from the county, Evans said. In exchange, Coriolis will commit to policies such as parental, sick, vacation and bereavement leave and provide affordable health insurance.
Why Morrisville?
Wiggenhorn told The News & Observer that building in Morrisville limits the time zone difference between the company’s U.S. lab and its lab in Planegg, Germany, to six hours. But what separated Morrisville from another East Coast hub like Boston?
“If we would have been in Boston, we would be close to our biotech clients, but not to our manufacturing partners,” Wiggenhorn said. “Where the manufacturing takes place, it’s the next level of success for every company.
“And this is why [Morrisville] is unique. In the U.S., I think it’s a unique combination you never find.”
Morrisville Mayor TJ Cawley told The N&O Wake Tech was touted to Coriolis as a place for the company to regularly train its employees. Having three top-60 universities, according to U.S. News and World Report, nearby also helped.
“Apple chose to build their newest campus here in this area because they are having trouble having hardware engineers go to the West Coast to live,” Cawley said. So people want to live here near where they went to school.”
Morrisville mayor pro tem Satish Garimella told The N&O to attract advanced manufacturing companies like Coriolis, the town first had to build more substations that run on clean energy. Garimella said Duke Energy is working on a substation down the street.
Garimella said according to Duke Energy, a biopharma company can use up to 20 megawatts a day. In contrast, an apartment complex needs half a megawatt a day.
Uncertain demand for space at Spark LS
Garimella said the Morrisville town council had turned down a proposed 1 million square foot project from Amazon in favor of the $1 billion Sparks LS campus. With limited space for development, Garimella said, the town wanted to use that space for high-paying, high-tech jobs.
“The future is in biopharma therapeutics and also [in] advanced manufacturing,” Garimella told The N&O. “So I thought it was the best fit for this area to have that.”
Coriolis’ investment comes at a time when the campus faces uncertain demand. On one hand, the Trump administration is cutting National Institutes of Health grants to local universities, lowering demand from research startups for lab space.
On the other hand, the threat of tariffs from the administration coupled with the COVID-19 pandemic upending global supply chains has pushed demand for tenant space in the U.S. On Monday, the drugmaker Biogen announced a $2 billion investment in its Research Triangle Park facilities, The N&O reported.
Wiggenhorn said even as other companies suffered lower demand over the past two years, Coriolis’ demand remained high. He said the company thinks it will have a high demand regardless of the broader economy.
Though Coriolis’ initial investment amounts to 1% of the cost of the Spark LS campus, for Cawley, the arrival of Coriolis will have a snowball effect.
“That will sort of open things up, because it’s proof of concept,” Cawley said. “Once some people come, then more people will come.”
This story was originally published July 22, 2025 at 6:51 PM with the headline "Morrisville’s $1 billion biotech hub announces its first tenant, a German company."
.jpg)